Advitech - Natural Products for Psoriasis

Print


Relative improvements of the double-blind versus placebo study endpoints – the vast majority of the patients improved all psoriasis assessment parameters from baseline at day 56 and day 112, indicating that patients could certainly benefit from further improvement with longer use of Dermylex™ (in blue in the diagram).

 
«Back


Send an Enquiry to this Company


The details you provide will not be used to send unsolicited emails.
For further information please read our Privacy Policy.




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

The website for the pharmaceutical industry